Biotech is booming — and startups are still dying
By many measures, biotech is booming. U.S. biotech IPO volume hit a five-year high in the third quarter, with nine offerings raising $2.4 billion, according to an analysis by the global investment bank Locust Walk. Dealmaking has also been robust, with …